BMKDF
Price:
$0.3549
Market Cap:
$48.34M
BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.
Industry
Medical - Diagnostics & Research
IPO Date
2015-03-23
Stock Exchange
OTC
Ticker
BMKDF
According to BioMark Diagnostics Inc.’s latest financial reports and current stock price. The company's current ROE is -732.10%. This represents a change of -10590.68% compared to the average of 6.98% of the last 4 quarters.
The mean historical ROE of BioMark Diagnostics Inc. over the last ten years is 261.83%. The current -732.10% ROE has changed -379.61% with respect to the historical average. Over the past ten years (40 quarters), BMKDF's ROE was at its highest in in the March 2021 quarter at 738.33%. The ROE was at its lowest in in the June 2025 quarter at -31.25%.
Average
261.83%
Median
194.48%
Minimum
-110.70%
Maximum
1.38%
Discovering the peaks and valleys of BioMark Diagnostics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 518.47%
Maximum Annual ROE = 1.38%
Minimum Annual Increase = -147.28%
Minimum Annual ROE = -110.70%
| Year | ROE | Change |
|---|---|---|
| 2025 | -110.70% | -147.28% |
| 2024 | 234.15% | 46.11% |
| 2023 | 160.25% | -29.93% |
| 2022 | 228.71% | -83.47% |
| 2021 | 1.38% | 399.88% |
| 2020 | 276.75% | 518.47% |
| 2019 | 44.75% | -44.56% |
| 2018 | 80.71% | 20.15% |
| 2017 | 67.17% | -73.46% |
| 2016 | 253.14% | -113.03% |
The current ROE of BioMark Diagnostics Inc. (BMKDF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
94.57%
5-year avg
379.16%
10-year avg
261.83%
BioMark Diagnostics Inc.’s ROE is greater than Cordlife Group Limited (-9.68%), less than Izotropic Corporation (67.02%), less than Marpai, Inc. (41.26%), greater than ImpediMed Limited (-80.35%), less than DIAGNOS Inc. (955.49%), less than Fluent Corp. (373.54%), greater than Evolva Holding S.A. (-13.27%), less than Celyad Oncology S.A. (67.42%), less than Rubicon Organics Inc. (0.61%), greater than Starpharma Holdings Limited (-47.38%),
| Company | ROE | Market cap |
|---|---|---|
| -9.68% | $26.11M | |
| 67.02% | $16.65M | |
| 41.26% | $11.99M | |
| -80.35% | $24.04M | |
| 955.49% | $24.51M | |
| 373.54% | $19.10M | |
| -13.27% | $7.93M | |
| 67.42% | $8.06M | |
| 0.61% | $21.83M | |
| -47.38% | $87.83M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioMark Diagnostics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioMark Diagnostics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BioMark Diagnostics Inc.'s ROE?
How is the ROE calculated for BioMark Diagnostics Inc. (BMKDF)?
What is the highest ROE for BioMark Diagnostics Inc. (BMKDF)?
What is the 3-year average ROE for BioMark Diagnostics Inc. (BMKDF)?
What is the 5-year average ROE for BioMark Diagnostics Inc. (BMKDF)?
How does the current ROE for BioMark Diagnostics Inc. (BMKDF) compare to its historical average?